AI-generated summary
The authors randomized dry eye patients with meibomian gland dysfunction to intense pulsed light treatment or sham treatment and measured tear cytokines and prostaglandin E2 over time. They report that IL-17A and IL-6 decreased compared with sham at each measured time point, and PGE2 decreased compared with sham at week 12. The authors describe these reductions as consistent with improvement in some clinical signs and symptoms.
- Who or what was studied
- Patients with dry eye disease owing to meibomian gland dysfunction
- Limits stated in the abstract
- The abstract does not state the number of participants, and it does not report the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 16 J/cm2, 0 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Sham, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.